Monitor TRex Bio's next quarterly filing for any change in this position; Johnson & Johnson's passive stake is a strategic corporate venture investment. No immediate catalyst.
Price Chart
Executive Summary
Johnson & Johnson Innovation-JJDC, Inc. (a wholly-owned subsidiary of Johnson & Johnson) disclosed a 5.3% passive stake in TRex Bio, Inc. via a Schedule 13G filed on October 15, 2026. The stake consists of 1,475,302 shares of common stock, held as a corporate venture investment following TRex Bio's IPO on October 13, 2026. This is a routine passive disclosure by a strategic corporate investor with no activist intent.
Key Financial Metrics
Key Facts
- Johnson & Johnson Innovation-JJDC, Inc. and Johnson & Johnson beneficially own 1,475,302 shares of TRex Bio common stock.
- The stake represents 5.3% of the 27,577,535 shares outstanding shares following the IPO on October 13, 2026.
- Filing is a passive Schedule 13G filed under Rule 13d-1(c), certifying no intent to influence or change control.
- Johnson & Johnson is a strategic corporate investor; the investment is held through its subsidiary JJDC, Inc.
Financial Impact
No financial impact from the filing; passive disclosure of a 5.3% stake valued at approximately $1.475M shares (based on IPO price not disclosed but implied by share count).
Risk Factors
- Johnson & Johnson could convert to a 13D if activist intent emerges, though currently certified passive.
- No change in the filing; no change in the filing.
- No change in the filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000904454-26-000517 |
| Document: 0000904454-26-000517-index-headers.html | 0000904454-26-000517 |
| Document: 0000904454-26-000517-index.html | 0000904454-26-000517 |
| Document: 0000904454-26-000517.txt | 0000904454-26-000517 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | SC 13G | $14.80 $14.44 | ▼ −2.43% | ▼ −2.77% | $13.87 (−6.28%) |
Oct 16, 2026 10d ago | SC 13D | $14.80 $14.44 | ▼ −2.43% | ▼ −2.77% | $13.87 (−6.28%) |
Oct 16, 2026 10d ago | SC 13D | $14.01 $14.80 | ▲ +5.64% | ▲ +5.22% | $13.87 (−1.00%) |
Oct 15, 2026 11d ago | Insider Cluster | $14.01 $14.80 | ▲ +5.64% | ▲ +5.22% | $13.87 (−1.00%) |
Oct 15, 2026 11d ago | SC 13G | $14.16 $14.01 | ▼ −1.06% | ▲ +0.05% | $13.87 (−2.05%) |
Oct 13, 2026 13d ago | Press Release | $13.50 $14.16 | ▲ +4.89% | ▲ +4.60% | $13.87 (+2.74%) |
Oct 9, 2026 17d ago | 424B4 | $14.03 $13.60 | ▼ −3.06% | ▼ −3.05% | $13.87 (−1.14%) |
Oct 9, 2026 17d ago | EFFECT | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.87 (−0.93%) |
Oct 8, 2026 18d ago | 3 | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.87 (−0.93%) |
Oct 8, 2026 18d ago | 3 | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.87 (−0.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers